WEISS MICHAEL S 4
4 · Checkpoint Therapeutics, Inc. · Filed May 16, 2024
Insider Transaction Report
Form 4
WEISS MICHAEL S
Director
Transactions
- Award
COMMON STOCK
2024-05-14+32,051→ 62,174 total(indirect: See Note 3) - Award
COMMON STOCK
2024-05-14+50,000→ 112,174 total(indirect: See Note 3)
Footnotes (4)
- [F1]The 32,051 shares of restricted Common Stock will vest on May 14, 2027, subject to Mr. Weiss's continued service on the board on such date.
- [F2]Includes restricted shares of Common Stock which vest over various time periods, subject to Mr. Weiss's continued service on the board.
- [F3]The shares are held by Hawkins BioVentures, LLC, of which Mr. Weiss is the sole member.
- [F4]The 50,000 shares of restricted Common Stock will vest according to the following schedule, subject to Mr. Weiss's continued service on the board on each date: one third on May 14, 2027, one third on May 14, 2028, and one third on May 14, 2029.